Volume 18, Number 3—March 2012

Dispatch

Hepatitis E Virus Infection in HIV-infected Persons

Nancy F. Crum-Cianflone , Jennifer Curry, Jan Drobeniuc, Amy Weintrob, Michael Landrum, Anuradha Ganesan, William Bradley, Brian K. Agan, Saleem Kamili, and The Infectious Disease Clinical Research Program HIV Working Group

Author affiliations: Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA (N.F. Crum-Cianflone, J. Curry, A. Weintrob, M. Landrum, A. Ganesan, W. Bradley, B.K. Agan); Naval Medical Center San Diego, San Diego, California, USA (N.F. Crum-Cianflone); Naval Medical Center Portsmouth, Portsmouth, Virginia, USA (J. Curry); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Drobeniuc S. Kamili); Walter Reed Army Medical Center, Washington DC, USA (A. Weintrob); San Antonio Military Medical Center, San Antonio, Texas, USA (M. Landrum); National Naval Medical Center, Bethesda (A. Ganesan)

Main Article

Figure 2

Figure 2. IgM and IgG against hepatitis E virus (HEV) signal/cutoff ratios for 7 HIV-infected US military beneficiaries with acute HEV infection, 1985–2009. Serum specimens were tested for HEV markers before and after alanine aminotransferase spike, indicated by 0.0 on x-axis. Horizontal lines indicate enzyme immunoassay signal/cutoff ratio of 1.0.

Main Article

¹Members are listed at the end of this article.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.